InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Gano Kyle, Chief Executive Officer. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 20 disclosures have been recorded. Split: 0 buy · 10 sells. Total volume traded: €1.2m. Activity tracked since 5 January 2022. The latest transaction was filed on 12 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gano Kyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
20 of 20 declarations
About Gano Kyle
Kyle Gano serves as Chief Executive Officer and Chief Business Development Officer at Neurocrine Biosciences Inc. He leads the company's strategic initiatives and oversees the development of new business opportunities. Kyle brings expertise in management and product development, contributing to innovation and growth at Neurocrine.
